extract: 2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy

Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70>

domains/health/Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md

@@ -36,6 +36,12 @@ OBBBA adds a second mechanism for US life expectancy decline: policy-driven cove
 
 ---
 
+### Additional Evidence (extend)
+*Source: [[2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy]] | Added: 2026-03-24*
+
+PNAS 2026 cohort analysis shows the deaths-of-despair framing is incomplete: post-1970 US birth cohorts show mortality deterioration not just in external causes (overdoses, suicide) but also in cardiovascular disease and cancer simultaneously. The problem is multi-causal across all three major cause categories, not primarily driven by external causes.
+
+
 Relevant Notes:
 - [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]] -- the US life expectancy reversal is the most dramatic empirical confirmation of this claim
 - healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured -- 75 percent of US healthcare dollars go to preventable diseases while government subsidizes the behaviors causing them

domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md

@@ -67,6 +67,12 @@ Amodei's complementary factors framework explicitly identifies 'human constraint
 
 ---
 
+### Additional Evidence (confirm)
+*Source: [[2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy]] | Added: 2026-03-24*
+
+PNAS 2026 attributes US life expectancy stagnation to 'a complex convergence of rising chronic disease, shifting behavioral risks, and increases in certain cancers among younger adults' — explicitly identifying behavioral and social factors as the drivers of cohort-level mortality deterioration, not medical care quality.
+
+
 Relevant Notes:
 - [[social isolation costs Medicare 7 billion annually and carries mortality risk equivalent to smoking 15 cigarettes per day making loneliness a clinical condition not a personal problem]] -- loneliness is one of the most actionable SDOH factors with clear cost signature and robust evidence
 - [[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]] -- the 90% finding motivates SDOH intervention but the implementation gap persists

inbox/archive/general/2026-02-24-nhs-dtac-v2-updated-form-april-6-deadline.md

@@ -0,0 +1,61 @@
+---
+type: source
+title: "NHS DTAC V2 (February 2026): Updated Form With 25% Fewer Questions, Mandatory From April 6, 2026"
+author: "NHS England / Periculo Cyber / Acorn Compliance"
+url: https://www.periculo.co.uk/cyber-security-blog/dtac-version-2-what-digital-health-organisations-need-to-know-before-6th-april-2026
+date: 2026-02-24
+domain: health
+secondary_domains: []
+format: news
+status: processed
+priority: low
+tags: [nhs-dtac, regulatory-compliance, digital-health, uk-healthcare, clinical-ai-safety, belief-5]
+---
+
+## Content
+
+NHS England published an updated DTAC form on February 24, 2026. Key changes:
+
+**What changed:**
+- 25% reduction in questions
+- De-duplicated with: DSPT (Data Security and Protection Toolkit) and pre-acquisition questionnaire
+- Clearer guidance on DTAC's purpose, scope, and how to complete assessments
+
+**What DIDN'T change:**
+- The five core DTAC domains: Clinical Safety, Data Protection, Technical Security, Interoperability, Usability & Accessibility
+- The substantive clinical safety requirements (DCB0129/DCB0160)
+- The requirement for all NHS digital health tool procurement to use DTAC assessment
+
+**Implementation:**
+- Previous version NOT to be used from April 6, 2026 onwards
+- Suppliers already on NHS supplier registries must transition to new form
+
+**This is a PROCEDURAL update, not a new substantive requirement.** The compliance bar for clinical AI tools has not been raised or lowered — it's been streamlined.
+
+Source also: Periculo Cyber (cyber security compliance specialists), Acorn Compliance (healthtech compliance), NHS Transformation Directorate guidance portal.
+
+## Agent Notes
+
+**Why this matters (or why it matters less than I anticipated):** When researching the "April 6 deadline" from Session 11, I expected to find new substantive requirements. Instead, it's a form update — 25% fewer questions, better documentation. This is administrative streamlining, not a regulatory tightening. The "mandatory" framing in NHS communications made this sound like a new compliance gate; it's actually just a form swap.
+
+**What surprised me:** The de-duplication with DSPT and pre-acquisition questionnaire. This reduces friction for suppliers completing DTAC — it makes compliance EASIER, not harder. This partially undermines the "regulatory pressure forcing OE to disclose safety data" thesis from Session 11 — DTAC V2 is less burdensome, not more.
+
+**What I expected but didn't find:** New Annex-III-style requirements for clinical AI specifically. The DTAC V2 update is general digital health governance (applies to apps, devices, platforms) — there's no AI-specific clinical safety update analogous to EU AI Act's Annex III. That remains a gap in UK regulation.
+
+**KB connections:**
+- This corrects an overstatement from Session 11: "NHS DTAC V2 is a mandatory clinical safety standard" is accurate but the "April 6, 2026 deadline" was framed as more consequential than it is
+- The substantive compliance requirement is DCB0160 (clinical safety risk assessment) — unchanged
+- The real regulatory pressure comes from the supplier registry (January 2026) and NHS procurement requirements — not DTAC V2 specifically
+- Does NOT represent a new forcing function for OE safety disclosure; suppliers already using previous DTAC form just switch forms
+
+**Extraction hints:**
+- Do NOT create a standalone claim for "DTAC V2 creates new compliance requirements" — it doesn't
+- The relevant claim is already in the KB or in the supplier registry source: "NHS procurement of digital health tools requires DTAC assessment + clinical safety case (DCB0160)"
+- This source is primarily a CORRECTION of Session 11's slightly elevated framing of the April 6 deadline
+
+**Context:** Multiple compliance advisory firms (Periculo, Acorn) confirm this interpretation — DTAC V2 is an administrative update, not a new compliance threshold.
+
+## Curator Notes
+PRIMARY CONNECTION: Session 11 regulatory track finding — corrects overstatement about April 6 deadline significance
+WHY ARCHIVED: Prevents future sessions from treating the DTAC V2 April 6 deadline as a major regulatory event — it's a form update, not a new substantive requirement
+EXTRACTION HINT: Do not extract as a standalone claim; use as context correction for Session 11 regulatory track framing

inbox/queue/.extraction-debug/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.json

@@ -0,0 +1,32 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "us-life-expectancy-stagnation-driven-by-post-1970-birth-cohort-mortality-deterioration-across-cvd-cancer-external-causes.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    },
+    {
+      "filename": "2010-period-effect-deteriorated-mortality-across-all-adult-us-cohorts-simultaneously-indicating-systemic-environmental-shift.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 2,
+    "kept": 0,
+    "fixed": 2,
+    "rejected": 2,
+    "fixes_applied": [
+      "us-life-expectancy-stagnation-driven-by-post-1970-birth-cohort-mortality-deterioration-across-cvd-cancer-external-causes.md:set_created:2026-03-24",
+      "2010-period-effect-deteriorated-mortality-across-all-adult-us-cohorts-simultaneously-indicating-systemic-environmental-shift.md:set_created:2026-03-24"
+    ],
+    "rejections": [
+      "us-life-expectancy-stagnation-driven-by-post-1970-birth-cohort-mortality-deterioration-across-cvd-cancer-external-causes.md:missing_attribution_extractor",
+      "2010-period-effect-deteriorated-mortality-across-all-adult-us-cohorts-simultaneously-indicating-systemic-environmental-shift.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-24"
+}

inbox/queue/2026-02-24-nhs-dtac-v2-updated-form-april-6-deadline.md

@@ -7,9 +7,12 @@ date: 2026-02-24
 domain: health
 secondary_domains: []
 format: news
-status: unprocessed
+status: enrichment
 priority: low
 tags: [nhs-dtac, regulatory-compliance, digital-health, uk-healthcare, clinical-ai-safety, belief-5]
+processed_by: vida
+processed_date: 2026-03-24
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -59,3 +62,13 @@ Source also: Periculo Cyber (cyber security compliance specialists), Acorn Compl
 PRIMARY CONNECTION: Session 11 regulatory track finding — corrects overstatement about April 6 deadline significance
 WHY ARCHIVED: Prevents future sessions from treating the DTAC V2 April 6 deadline as a major regulatory event — it's a form update, not a new substantive requirement
 EXTRACTION HINT: Do not extract as a standalone claim; use as context correction for Session 11 regulatory track framing
+
+
+## Key Facts
+- NHS DTAC V2 published February 24, 2026
+- DTAC V2 has 25% fewer questions than V1
+- DTAC V2 de-duplicates with DSPT (Data Security and Protection Toolkit) and pre-acquisition questionnaire
+- DTAC V2 mandatory from April 6, 2026
+- Five core DTAC domains unchanged: Clinical Safety, Data Protection, Technical Security, Interoperability, Usability & Accessibility
+- DCB0129/DCB0160 clinical safety requirements unchanged
+- Previous DTAC version not to be used from April 6, 2026 onwards

inbox/queue/2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy.md

@@ -7,9 +7,13 @@ date: 2026-03-10
 domain: health
 secondary_domains: []
 format: research-paper
-status: unprocessed
+status: enrichment
 priority: high
 tags: [life-expectancy, deaths-of-despair, birth-cohort, cardiovascular-disease, cancer, external-causes, mortality-trends, healthspan, belief-1]
+processed_by: vida
+processed_date: 2026-03-24
+enrichments_applied: ["Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md", "medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -55,3 +59,10 @@ Coverage: News-Medical.net (March 10), UTMB newsroom (March 9), Subodh Verma MD
 PRIMARY CONNECTION: Belief 1 "healthspan is civilization's binding constraint" — structural confirmation
 WHY ARCHIVED: Direct disconfirmation target for Belief 1 in Session 12; result is that Belief 1 is CONFIRMED and STRENGTHENED, not disconfirmed
 EXTRACTION HINT: Extract as TWO claims: (1) post-1970 cohort mortality deterioration across CVD+cancer+external causes; (2) 2010 period-effect deteriorating all adult cohorts simultaneously — these have different causal implications
+
+
+## Key Facts
+- CDC released 2024 US life expectancy data showing 79.0 years (up 0.6 from 78.4 in 2023)
+- PNAS published companion paper 'Cohort mortality forecasts indicate signs of deceleration in life expectancy gains' (doi: 10.1073/pnas.2519179122)
+- Study analyzed mortality changes from 1979–2023 for all-cause mortality and three cause groups (cardiovascular disease, cancer, external causes) across cohorts born between the 1890s and 1980s
+- 1950s birth cohort identified as inflection point where mortality improvements gave way to deterioration